China Post-approval Commitment (PAC) Study of Avalglucosidase Alfa in Participants With IOPD | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
China Post-approval Commitment (PAC) Study of Avalglucosidase Alfa in Participants With IOPD	Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Lysosomal Storage Diseases, Nervous System, Nutritional and Metabolic Diseases, brain disorder, central nervous system disorder, disorder of glycogen metabolism, glycogen storage disease II, hereditary disease, inborn carbohydrate metabolic disorder, inborn errors of metabolism, lysosomal storage disease, metabolic disease, nervous system disorder	Recruiting	Phase 4	2026-03-23		NCT06666413

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Genzyme, a Sanofi Company	22

0 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
No products are listed yet.